Effective January 1, 2026, Medi-Cal Rx is excluding coverage for GLP-1 medications prescribed for weight loss: [12] Wegovy, Zepbound, Saxenda: Completely removed from the Contract Drugs List for weight loss Ozempic, Mounjaro, Rybelsus: Restricted to Type 2 diabetes onlyweight loss claims will auto-deny Existing prior authorizations end December 31, 2025 Exceptions: Members under age 21 may still qualify via EPSDT Non-weight-loss indications (Zepbound for OSA, Wegovy for cardiovascular) may still get PA approval This does NOT affect Kaiser commercial or employer-sponsored plansonly Medi-Cal members
Lets dive into the eight standout benefits that make this treatment so remarkable
doi: 10.1038/ng0195-31
CLOPINASE 75 TABLET - Clopidogrel Bisulphate eq
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, GLP-1 weight management support, longevity protocols, and related precision wellness services
Contiene cafena (13,4 mg por cpsula)
